TABLE 2.
PEDro score of the selected studies
| First author | Items | Total score/10 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ||
| Brodie et al. | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Chan et al. | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 4 |
| Finn et al. | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 4 |
| Ramadugu et al. | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 7 |
| Rothgangel et al. | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8 |
Note: Criterion 1: eligibility criteria were specified; criterion 2: subjects were randomly allocated to groups; criterion 3: allocation was concealed; criterion 4: at baseline, the most important prognostic indicators were similar between groups; criterion 5: blinding of all subjects; criterion 6: blinding of all therapists who administered the therapy; criterion 7: blinding of all assessors who measured at least one key outcome; criterion 8: measures of at least one key outcome were obtained from more than 85% of the subjects initially allocated to groups; criterion 9: all subjects for whom outcome measures were available received the treatment or control condition, as allocated; criterion 10: the results of between‐group statistical comparisons are reported for at least one key outcome; criterion 11: the study provides both point measures and variability measures for at least one key outcome.